Erratum: SOX9 Regulates Multiple Genes in Chondrocytes, Including Genes Encoding ECM Proteins, ECM Modification Enzymes, Receptors, and Transporters (PLoS ONE (2015) 10:1 (e0143156) DOI:10.1371/journal.pone.0107577);SOX9 regulates multiple genes in chondrocytes, including genes encoding ECM proteins, ECM modification enzymes, receptors, and transporters

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Oh, Chun Do ^a,c   Lu, Yue ^a   Liang, Shoudan ^a   Mori Akiyama, Yuko ^b   Chen, Di ^c   De Crombrugghe, Benoit ^a   Yasuda, Hideyo ^a,d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c RUSH UNIVERSITY   (United States)

^d Mariabiotech Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; MEMBRANE RECEPTOR; MESSENGER RNA; SCLEROPROTEIN; TRANSCRIPTION FACTOR SOX9; TRANSFERASE; PROTEIN BINDING;

ADENOVIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CARTILAGE CELL; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX GENE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENOME; MOUSE; NONHUMAN; PLASMID; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIB; RNA SEQUENCE; ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; KNOCKOUT MOUSE; METABOLISM; NUCLEOTIDE MOTIF; POSITION WEIGHT MATRIX; PROTEIN TRANSPORT;

ANIMALS; BINDING SITES; CHONDROCYTES; CHROMATIN IMMUNOPRECIPITATION; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICE; MICE, KNOCKOUT; NUCLEOTIDE MOTIFS; POSITION-SPECIFIC SCORING MATRICES; PROTEIN BINDING; PROTEIN TRANSPORT; SOX9 TRANSCRIPTION FACTOR;

EID: 84907190232     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143156     Document Type: Erratum

References (54)

1. Kist R, Schrewe H, Balling R, Scherer G (2002) Conditional inactivation of Sox9: a mouse model for campomelic dysplasia. Genesis 32: 121-123.
2. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16: 2813-2828.
3. Bi W, Huang W, Whitworth DJ, Deng JM, Zhang Z, et al. (2001) Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A 98: 6698-6703.
4. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, et al. (1994) Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372: 525-530.
5. Benko S, Fantes JA, Amiel J, Kleinjan DJ, Thomas S, et al. (2009) Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat Genet 41: 359-364.
6. Bridgewater LC, Lefebvre V, de Crombrugghe B (1998) Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem 273: 14998-15006.
7. Xie WF, Zhang X, Sakano S, Lefebvre V, Sandell LJ (1999) Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res 14: 757-763.
8. Sekiya I, Tsuji K, Koopman P, Watanabe H, Yamada Y, et al. (2000) SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 275: 10738-10744.
9. Barbara NP, Wrana JL, Letarte M (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 274: 584-594.
10. Murakami S, Kan M, McKeehan WL, de Crombrugghe B (2000) Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A 97: 1113-1118.
11. Murakami S, Lefebvre V, de Crombrugghe B (2000) Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem 275: 3687-3692.
12. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
13. Huang BL, Brugger SM, Lyons KM (2010) Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin. J Biol Chem 285: 27702-27712.
14. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B (2001) The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci U S A 98: 160-165.
15. Pepke S, Wold B, Mortazavi A (2009) Computation for ChIP-seq and RNA-seq studies. Nat Methods 6: S22-32.
16. Singh-Gasson S, Green RD, Yue Y, Nelson C, Blattner F, et al. (1999) Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array. Nat Biotechnol 17: 974-978.
17. Liu S, Ren H, Gao Q, Roach DJ, Loder RT, Jr., et al. (2000) Automated parallel DNA sequencing on multiple channel microchips. Proc Natl Acad Sci U S A 97: 5369-5374.
18. Hall CR, Cole WG, Haynes R, Hecht JT (2002) Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis. Am J Med Genet 112: 1-5.
19. Wakahara T, Kusu N, Yamauchi H, Kimura I, Konishi M, et al. (2007) Fibin, a novel secreted lateral plate mesoderm signal, is essential for pectoral fin bud initiation in zebrafish. Dev Biol 303: 527-535.
20. Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, et al. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78: 335-342.
21. Shung CY, Ota S, Zhou ZQ, Keene DR, Hurlin PJ (2012) Disruption of a Sox9-beta-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II. Hum Mol Genet 21: 4628-4644.
22. Xu L, Tan L, Goldring MB, Olsen BR, Li Y (2001) Expression of frizzled genes in mouse costochondral chondrocytes. Matrix Biol 20: 147-151.
23. Leijten J, Bos SD, Landman EB, Georgi N, Jahr H, et al. (2013) GREM1, FRZB and DKK1 mRNA levels correlate with osteoarthritis and are regulated by osteoarthritis-associated factors. Arthritis Res Ther 15: R126.
24. Hoang B, Moos M Jr, Vukicevic S, Luyten FP (1996) Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem 271: 26131-26137.
25. Johnson EB, Hammer RE, Herz J (2005) Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. Hum Mol Genet 14: 3523-3538.
26. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, et al. (2004) Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18: 1072-1087.
27. Camper L, Holmvall K, Wangnerud C, Aszodi A, Lundgren-Akerlund E (2001) Distribution of the collagen-binding integrin alpha10beta1 during mouse development. Cell Tissue Res 306: 107-116.
28. Kingsley DM, Bland AE, Grubber JM, Marker PC, Russell LB, et al. (1992) The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell 71: 399-410.
29. Wroblewski J, Edwall C (1992) PDGF BB stimulates proliferation and differentiation in cultured chondrocytes from rat rib growth plate. Cell Biol Int Rep 16: 133-144.
30. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17: 2336-2346.
31. Oh CD, Maity SN, Lu JF, Zhang J, Liang S, et al. (2010) Identification of SOX9 interaction sites in the genome of chondrocytes. PLoS One 5: e10113.
32. Mukhopadhyay K, Lefebvre V, Zhou G, Garofalo S, Kimura JH, et al. (1995) Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene. J Biol Chem 270: 27711-27719.
33. Han Y, Lefebvre V (2008) L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol 28: 4999-5013.
34. Johnson K, Zhu S, Tremblay MS, Payette JN, Wang J, et al. (2012) A stem cellbased approach to cartilage repair. Science 336: 717-721.
35. Genzer MA, Bridgewater LC (2007) A Col9a1 enhancer element activated by two interdependent SOX9 dimers. Nucleic Acids Res 35: 1178-1186.
36. Bridgewater LC, Walker MD, Miller GC, Ellison TA, Holsinger LD, et al. (2003) Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements. Nucleic Acids Res 31: 1541-1553.
37. Sock E, Pagon RA, Keymolen K, Lissens W, Wegner M, et al. (2003) Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia. Hum Mol Genet 12: 1439-1447.
38. Coustry F, Oh CD, Hattori T, Maity SN, de Crombrugghe B, et al. (2010) The dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA template. Nucleic Acids Res 38: 6018-6028.
39. Bernard P, Tang P, Liu S, Dewing P, Harley VR, et al. (2003) Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum Mol Genet 12: 1755-1765.
40. Kawaguchi Y (2013) Sox9 and programming of liver and pancreatic progenitors. J Clin Invest 123: 1881-1886.
41. Seymour PA, Freude KK, Tran MN, Mayes EE, Jensen J, et al. (2007) SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl Acad Sci U S A 104: 1865-1870.
42. Cancer Genome Atlas N (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
43. Matheu A, Collado M, Wise C, Manterola L, Cekaite L, et al. (2012) Oncogenicity of the developmental transcription factor Sox9. Cancer Res 72: 1301-1315.
44. Tsuda M, Takahashi S, Takahashi Y, Asahara H (2003) Transcriptional coactivators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J Biol Chem 278: 27224-27229.
45. Hattori T, Coustry F, Stephens S, Eberspaecher H, Takigawa M, et al. (2008) Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5. Nucleic Acids Res 36: 3011-3024.
46. Amano K, Hata K, Muramatsu S, Wakabayashi M, Takigawa Y, et al. (2011) Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcription. Mol Biol Cell 22: 1300-1311.
47. Takigawa Y, Hata K, Muramatsu S, Amano K, Ono K, et al. (2010) The transcription factor Znf219 regulates chondrocyte differentiation by assembling a transcription factory with Sox9. J Cell Sci 123: 3780-3788.
48. Nakamura Y, Yamamoto K, He X, Otsuki B, Kim Y, et al. (2011) Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat Commun 2: 251.
49. Lefebvre V, Li P, de Crombrugghe B (1998) A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17: 5718-5733.
50. Shi Z, Chiang CI, Mistretta TA, Major A, Mori-Akiyama Y (2013) SOX9 directly regulates IGFBP-4 in the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 305: G74-83.
51. Arango NA, Lovell-Badge R, Behringer RR (1999) Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 99: 409-419.
52. Passeron T, Valencia JC, Bertolotto C, Hoashi T, Le Pape E, et al. (2007) SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation. Proc Natl Acad Sci U S A 104: 13984-13989.
53. Zalzali H, Naudin C, Bastide P, Quittau-Prevostel C, Yaghi C, et al. (2008) CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. Oncogene 27: 7131-7138.
54. Lefebvre V, Garofalo S, Zhou G, Metsaranta M, Vuorio E, et al. (1994) Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol 14: 329-335.